WS Data Solutions
Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Buy
Analyst Rating
Neutral
Simple Moving Average
Sell
Exponential Moving Average
Sell
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
SAB Biotherapeutics, Inc. Common Stock (SABS)
Biological Products, (no Disgnostic Substances)
https://www.sabbiotherapeutics.com
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
2100 EAST 54TH STREET NORTH
SIOUX FALLS, SD
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
10/22/2021
Market Cap
22,150,248
Shares Outstanding
9,230,000
Weighted SO
9,225,000
Total Employees
N/A
Upcoming Earnings
08/19/2024
Similar Tickers
Beta
0.6890
Last Div
0.0000
Range
2.16-10.5
Chg
0.1500
Avg Vol
17153
Mkt Cap
22150248
Exch
NASDAQ
Country
US
Phone
605 679 6980
DCF Diff
-3.7064
DCF
6.0464
Div Yield
0.0000
P/S
7.9675
EV Multiple
-0.2516
P/FV
0.4816
Div Yield %
0.0000
P/E
-0.5509
PEG
0.0071
Payout
0.0000
Current Ratio
5.2411
Quick Ratio
5.2411
Cash Ratio
2.2832
DSO
29.5305
DIO
0.0000
Op Cycle
29.5305
DPO
86.6006
CCC
-57.0701
Gross Margin
-0.7757
Op Margin
-16.4704
Pretax Margin
-14.5033
Net Margin
-14.5033
Eff Tax Rate
0.3276
ROA
-0.6515
ROE
-0.9404
ROCE
-0.8426
NI/EBT
1.0000
EBT/EBIT
0.8806
EBIT/Rev
-16.4704
Debt Ratio
0.0863
D/E
0.1158
LT Debt/Cap
0.0822
Total Debt/Cap
0.1038
Int Coverage
-349.9860
CF/Debt
-6.9849
Equity Multi
1.3420
Rec Turnover
12.3601
Pay Turnover
4.2147
Inv Turnover
0.0000
FA Turnover
0.1276
Asset Turnover
0.0449
OCF/Share
-4.0322
FCF/Share
-4.0684
Cash/Share
4.0331
OCF/Sales
-13.4235
FCF/OCF
1.0090
CF Coverage
-6.9849
ST Coverage
-30.7980
CapEx Coverage
-111.4798
Div&CapEx Cov
-111.4798
P/BV
0.4816
P/B
0.4816
P/S
7.9675
P/E
-0.5509
P/FCF
-0.5883
P/OCF
-0.5952
P/CF
-0.5952
PEG
0.0071
P/S
7.9675
EV Multiple
-0.2516
P/FV
0.4816
DPS
0.0000